Starting in autumn 2026, England’s pharmacies will play a expanded role in primary care, allowing patients to access treatment for more conditions without first visiting a general practitioner (GP). This initiative, part of a £340 million government investment, aims to reduce pressure on GP services by enabling community pharmacists with specialized training to independently prescribe medications for certain health issues officially announced by the Department of Health and Social Care.
Key Changes to the Pharmacy First Scheme
The expansion builds on the existing Pharmacy First program, which currently allows pharmacists to provide advice, over-the-counter treatments, and prescription-only medicines for seven conditions, including sore throat, earache, and urinary tract infections. Starting in 2026, five additional conditions will be added, though specifics have not yet been disclosed official government guidance.
Pharmacists will also be authorized to offer care for eye, ear, oral, and dental issues, as well as digestive problems. The move aligns with the government’s goal of “giving patients more care right on their doorstep,” according to Health Minister Stephen Kinnock statement.
Benefits for Patients and the NHS
The shift is expected to improve healthcare access, particularly for minor ailments that currently require GP appointments. Data from the 2025–2026 period shows over 3.3 million Pharmacy First consultations, a 43% increase from the prior year NHS statistics. By delegating routine cases to pharmacies, GPs can focus on more complex patient needs.
Dr. Amanda Doyle, NHS England’s national director for primary care, emphasized that the expansion “makes better use of community pharmacy teams’ clinical expertise” NHS England statement.
Sector Raises Funding Concerns
Despite the optimism, the National Pharmacy Association (NPA) has warned that the funding package “does very little” to address a £2.5 billion shortfall in community pharmacy budgets NPA press release. NPA chairman Dr. Olivier Picard stressed that without additional investment, many pharmacies may struggle to implement the new prescribing roles, risking the initiative’s success.
“Pharmacies cannot sustain yet more loss-making work,” he said, urging the government to prioritize long-term financial stability alongside service expansion NPA statement.
What This Means for Patients
Patients in England can expect faster access to care for common conditions, potentially reducing wait times for GPs. However, the success of the program hinges on sufficient funding and training for pharmacists. As the rollout approaches, stakeholders will be closely monitoring how well the system adapts to increased responsibilities.
Key Takeaways
- The UK government is expanding pharmacist prescribing rights to ease GP workload.
- The Pharmacy First scheme will cover five additional conditions starting in 2026.
- Pharmacists will handle minor ailments, eye/ear care, and digestive issues.
- The National Pharmacy Association warns of funding gaps that could hinder implementation.
FAQs
How will this affect my GP visits?
Patients with minor conditions may no longer need to see a GP, as pharmacists will provide treatment and prescriptions directly.
Will all pharmacies be able to prescribe?
No—only pharmacists with specific qualifications in independent prescribing will be authorized to do so.
What are the risks of this expansion?
Concerns include potential overburdening of pharmacies without adequate funding and the need for clear guidelines to ensure patient safety.